MVision secured a $1.65M capital investment round led by Voima Ventures.
MVision, a Helsinki, Finland-based radiotherapy SaaS company announced that it completed a $1.65 million seed investment round.
The funding round was led by Voima Ventures and included financial participation from existing investors.
MVision, founded in 2017 by CEO Mahmudul Hasan, Aleksi Nurmi, Jarkko Niemela and Saad Ullah Akram, developed a SaaS-based auto-contouring service that speeds up radiotherapy treatment planning and streamlines the whole process from weeks and days to hours. The company's product is being used in hospitals in Finland and Germany as it streamlines the existing treatment planning process and significantly reduces the time spent on OAR contouring.